Long-term Cardiovascular Safety of Ustekinumab in Psoriasis and Psoriatic Arthritis: Results from an Observational Post-Authorization Safety Study Based on Swedish National Registers
{{output}}
Background: Evidence on the comparative cardiovascular safety of ustekinumab in psoriasis (PsO) and psoriatic arthritis (PsA) remains limited. Objective: ... ...
